ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $520,000 | – | 1,000,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 18,764 | $9,907,000 | 0.77% |
| Pentwater Capital Management LP | 46,411,000 | $24,770,000 | 0.27% |
| WHITEBOX ADVISORS LLC | 22,500,000 | $11,756,000 | 0.24% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,993,000 | 0.23% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,590,000 | $9,286,000 | 0.20% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $12,540,000 | 0.18% |
| BlueCrest Capital Management Ltd | 7,000,000 | $3,705,000 | 0.12% |
| DCF Advisers, LLC | 400,000 | $211,000 | 0.09% |
| Walleye Capital LLC | 5,000 | $2,638,000 | 0.08% |
| INGALLS & SNYDER LLC | 883,000 | $461,000 | 0.02% |